Could this be the secret to Pfizer's rebound strategy?
23don MSN
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
Pfizer's business may be in better shape than investors think.
Pfizer CEO Albert Bourla reflects on leadership through Covid successes and post-pandemic challenges
A symbol of American pharmaceutical innovation for nearly two centuries, Pfizer now faces the challenges of AI adoption and the promise of smarter medicines. Pfizer CEO Albert Bourla discussed ...
Many of us can easily pinpoint the artificial intelligence (AI) investments in our portfolios. Maybe you've bought shares of AI company stocks or invested in ETFs focused on AI, technology, or ...
If it weren't for question marks about its future growth, Pfizer (NYSE: PFE) stock would undoubtedly be trading at a much higher price. Sales were down last year, and the stock has been floundering, ...
Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results